UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G
Under the
Securities Exchange Act of 1934
(Amendment
No. 1)
Enzon
Pharmaceuticals Inc.
---------------------------------------
NAME OF
ISSUER:
Common
Stock (Par Value $0.01)
---------------------------------------
TITLE OF
CLASS OF SECURITIES
293904108
-------------------------------------
CUSIP
NUMBER
December
31, 2009
---------------------------------------
(Date of
Event Which Requires Filing of this Statement)
Check the
appropriate box to designate the rule pursuant to which this
Schedule
is filed:
[x] Rule
13d-1(b)
[ ] Rule
13d-1(c)
[ ] Rule
13d-1(d)
|
1.
|
NAME
OF REPORTING PERSONS
|
Deutsche
Bank AG*
|
2.
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A
GROUP
|
|
|
(A)
|
[
]
|
|
|
(B)
|
[
]
|
|
3.
|
SEC
USE ONLY
|
|
4.
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
|
Federal
Republic of Germany
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
5. SOLE
VOTING POWER
2,142,306
|
|
6. SHARED
VOTING POWER
0
|
|
|
7. SOLE
DISPOSITIVE POWER
2,142,306
|
|
|
8. SHARED
DISPOSITIVE POWER
0
|
|
9.
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
|
2,142,306
|
10.
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN
SHARES
|
[
]
|
11.
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW
9
|
4.50%
|
12.
|
TYPE
OF REPORTING PERSON
|
FI
* In
accordance with Securities Exchange Act Release No. 39538 (January 12, 1998),
this filing reflects the securities beneficially owned by the Corporate and
Investment Banking business group and the Corporate Investments business group
(collectively, "CIB") of Deutsche Bank AG and its subsidiaries and affiliates
(collectively, "DBAG"). This filing does not reflect securities, if any,
beneficially owned by any other business group of DBAG. Consistent with Rule
13d-4 under the Securities Exchange Act of 1934 ("Act"), this filing shall not
be construed as an admission that CIB is, for purposes of Section 13(d) under
the Act, the beneficial owner of any securities covered by the filing.
Furthermore, CIB disclaims beneficial ownership of the securities beneficially
owned by (i) any client accounts with respect to which CIB or its employees have
voting or investment discretion, or both, and (ii) certain investment entities,
of which CIB is the general partner, managing general partner, or other manager,
to the extent interests in such entities are held by persons other than
CIB.
|
Item
1(a).
|
Name
of Issuer:
|
|
|
Enzon
Pharmaceuticals Inc. (the "Issuer")
|
|
Item
1(b).
|
Address
of Issuer's Principal Executive
Offices:
|
|
|
685
Route 202/206
|
|
|
Bridgewater,
NJ 08807
|
|
|
United
States
|
|
Item
2(a).
|
Name
of Person Filing:
|
|
|
This
statement is filed on behalf of Deutsche Bank AG ("Reporting
Person").
|
|
Item
2(b).
|
Address
of Principal Business Office or, if none,
Residence:
|
|
|
Theodor-Heuss-Allee
70
|
|
|
60468
Frankfurt am Main
|
|
|
Federal
Republic of Germany
|
|
Item
2(c).
|
Citizenship:
|
|
|
The
citizenship of the Reporting Person is set forth on the cover
page.
|
|
Item
2(d).
|
Title
of Class of Securities:
|
|
|
The
title of the securities is common stock, $0.01 par value ("Common
Stock").
|
|
Item
2(e).
|
CUSIP
Number:
|
|
|
The
CUSIP number of the Common Stock is set forth on the cover
page.
|
|
Item
3.
|
If
this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c),
check whether the person filing is
a:
|
|
|
(a)
|
[
]
|
Broker
or dealer registered under section 15 of the
Act;
|
|
|
(b)
|
[
]
|
Bank
as defined in section 3(a)(6) of the
Act;
|
|
|
(c)
|
[
]
|
Insurance
Company as defined in section 3(a)(19) of the
Act;
|
|
|
(d)
|
[
]
|
Investment
Company registered under section 8 of the Investment Company Act of
1940;
|
|
|
(e)
|
[
]
|
An
investment adviser in accordance with Rule 13d-1(b)
(1)(ii)(E);
|
|
|
(f)
|
[
]
|
An
employee benefit plan, or endowment fund in accordance with Rule 13d-1
(b)(1)(ii)(F);
|
|
|
(g)
|
[
]
|
parent
holding company or control person in accordance with Rule 13d-1
(b)(1)(ii)(G);
|
|
|
(h)
|
[
]
|
A
savings association as defined in section 3(b) of the Federal Deposit
Insurance Act;
|
|
|
(i)
|
[
]
|
A
church plan that is excluded from the definition of an investment company
under section 3(c)(14) of the Investment Company Act of
1940;
|
|
|
(j)
|
[X]
|
A
non-U.S. institution in accordance with Group, in accordance with Rule
13d-1 (b)(1)(ii)(J).
|
|
|
(k)
|
[
]
|
Group,
in accordance with Rule 13d-1
(b)(1)(ii)(J).
|
|
Item
4.
|
Ownership.
|
|
|
(a)
|
Amount
beneficially owned:
|
|
|
The
Reporting Person owns the amount of the Common Stock as set forth on the
cover page.
|
|
|
(b)
|
Percent
of class:
|
|
|
The
Reporting Person owns the percentage of the Common Stock as set forth on
the cover page.
|
|
|
(a)
|
Number
of shares as to which such person
has:
|
|
|
(i)
|
sole
power to vote or to direct the
vote:
|
The
Reporting Person has the sole power to vote or direct the vote of the Common
Stock as set forth on the cover page.
|
|
(ii)
|
shared
power to vote or to direct the
vote:
|
The
Reporting Person has the shared power to vote or direct the vote of the Common
Stock as set forth on the cover page.
|
|
(iii)
|
sole
power to dispose or to direct the disposition
of:
|
The
Reporting Person has the sole power to dispose or direct the disposition of the
Common Stock as set forth on the cover page.
|
|
(iv)
|
shared
power to dispose or to direct the disposition
of:
|
The
Reporting Person has the shared power to dispose or direct the disposition of
the Common Stock as set forth on the cover page.
|
Item
5.
|
Ownership
of Five Percent or Less of a Class.
|
If this
statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following [X].
|
Item
6.
|
Ownership
of More than Five Percent on Behalf of Another
Person.
|
Not
applicable.
|
Item
7.
|
Identification
and Classification of the Subsidiary Which Acquired the Security Being
Reported on by the Parent Holding
Company.
|
Not
applicable.
|
Item
8.
|
Identification
and Classification of Members of the
Group.
|
Not
applicable.
|
Item
9.
|
Notice
of Dissolution of Group.
|
Not
applicable.
|
Item
10.
|
Certification.
|
By signing below I certify that, to the
best of my knowledge and belief, the foreign regulatory scheme applicable to a
bank organized under the laws of the Federal Republic of Germany is
substantially comparable to the regulatory scheme applicable to the functionally
equivalent U.S. institution. I also undertake to furnish to the Commission
staff, upon request, information that would otherwise be disclosed in a Schedule
13D.
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement is true, complete and
correct.
Dated: February
16, 2010
Deutsche
Bank AG
|
|
By:
|
/s/
Jeffrey A. Ruiz
|
|
|
Name:
|
Jeffrey
A. Ruiz
|
|
|
Title:
|
Director
|
|
|
By:
|
/s/
Cesar A. Coy
|
|
|
Name:
|
Cesar
A. Coy
|
|
|
Title:
|
Assistant
Vice President
|